Literature DB >> 6577285

Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.

M M Le Beau, R A Larson, M A Bitter, J W Vardiman, H M Golomb, J D Rowley.   

Abstract

We identified 18 patients with an inversion of chromosome 16, inv(16)(p13q22), among 308 patients with newly diagnosed acute nonlymphocytic leukemia. Each of these 18 patients had acute myelomonocytic leukemia (M4 subtype) and eosinophils with distinctly abnormal morphology, cytochemical staining, and ultrastructure. These eosinophils constituted from 1 to 33 per cent of the nucleated marrow cells. In our series, every patient with acute myelomonocytic leukemia and abnormal eosinophils also had an abnormal chromosome 16. This subgroup of M4 patients had a good response to intensive therapy designed to induce remission; 13 of 17 treated patients entered a complete remission, and 10 remain in first remission. Thus, patients with an inversion of chromosome 16 appear to represent a unique cytogenetic-clinicopathological subtype of acute nonlymphocytic leukemia with a favorable prognosis.

Entities:  

Mesh:

Year:  1983        PMID: 6577285     DOI: 10.1056/NEJM198309153091103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  61 in total

1.  RUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1).

Authors:  R Katherine Hyde; P Paul Liu
Journal:  J Cell Biochem       Date:  2010-08-01       Impact factor: 4.429

2.  The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression.

Authors:  C S Shelley; M A Arnaout
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 3.  Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.

Authors:  Peter H Wiernik
Journal:  Med Oncol       Date:  2014-07-22       Impact factor: 3.064

Review 4.  Chromosome abnormalities in acute leukemia: its clinical implications and age of onset.

Authors:  R Abe; Y Shiga; T Uchida; S Kariyone
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

5.  Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.

Authors:  R Katherine Hyde; Yasuhiko Kamikubo; Stacie Anderson; Martha Kirby; Lemlem Alemu; Ling Zhao; P Paul Liu
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

6.  Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.

Authors:  T Haferlach; W Gassmann; H Löffler; C Jürgensen; J Noak; W D Ludwig; E Thiel; D Haase; C Fonatsch; R Becher
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

7.  Fragile sites and structural rearrangements in cancer.

Authors:  M De Braekeleer; B Smith; C C Lin
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Acute eosinophilic leukemia: characterization by cytochemistry, chromosomal analysis, and in vitro colony formation.

Authors:  N Schmitz; P A Maubach; E Gödde-Salz; W Gassmann; H Löffler
Journal:  Klin Wochenschr       Date:  1985-02-04

9.  Acute myelomonocytic leukaemia following atypical congenital rubella.

Authors:  S J Kelly; T Gibbs; C H Cheetham
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

10.  Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU.

Authors:  K V Shepard; R Larson; M M Le Beau; L Leichman; B Levin
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.